https://investors.chemomab.com/ https://investors.chemomab.com/2026-07-08-Chemomab-Therapeutics-and-Precision-Medicine-Pioneer-Scipher-Medicine-Announce-Merger-Agreement-to-Advance-Nebokitug-in-an-AI-Powered-Phase-2-Trial-in-Rheumatoid-Arthritis Wed, 08 Jul 2026 07:30:00 -0400 https://investors.chemomab.com/2026-07-08-Chemomab-Therapeutics-and-Precision-Medicine-Pioneer-Scipher-Medicine-Announce-Merger-Agreement-to-Advance-Nebokitug-in-an-AI-Powered-Phase-2-Trial-in-Rheumatoid-Arthritis https://investors.chemomab.com/2026-05-14-Chemomab-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update Thu, 14 May 2026 08:00:00 -0400 https://investors.chemomab.com/2026-05-14-Chemomab-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update https://investors.chemomab.com/2026-03-19-Chemomab-Therapeutics-Announces-Year-End-and-Fourth-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update Thu, 19 Mar 2026 08:00:00 -0400 https://investors.chemomab.com/2026-03-19-Chemomab-Therapeutics-Announces-Year-End-and-Fourth-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update https://investors.chemomab.com/2026-02-17-Chemomab-Therapeutics-to-Participate-in-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference Tue, 17 Feb 2026 08:00:00 -0500 https://investors.chemomab.com/2026-02-17-Chemomab-Therapeutics-to-Participate-in-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference https://investors.chemomab.com/2025-12-02-Chemomab-Therapeutics-Announces-Nebokitug-Phase-2-SPRING-Trial-Results-in-Primary-Sclerosing-Cholangitis-Published-in-the-American-Journal-of-Gastroenterology Tue, 02 Dec 2025 08:00:00 -0500 https://investors.chemomab.com/2025-12-02-Chemomab-Therapeutics-Announces-Nebokitug-Phase-2-SPRING-Trial-Results-in-Primary-Sclerosing-Cholangitis-Published-in-the-American-Journal-of-Gastroenterology